Last News Cariprazina is coming to Italy. New drug for schizophrenia Financial news and new initiatives Who we are Recordati is an established international pharmaceutical group, partner of important companies. >> Rare diseases Every patient with a rare disease has the right to the best possible treatment. >> Research and development With an eye to the future, the Recordati Group makes substantial investments in research and development. >> International presence Recordati in the world, an international development strategy. >> Partnering Always committed to the creation of future value through a careful policy of alliances >> The Recordati - Investors Share “The most valuable currency in the financial markets is reliable information”. (Michael Bloomberg, Mary Shapiro) >> Annual balance Institutional Brochure The Prize Alert Service Italian | English Company data Recordati SpA via M. Civitali 1, 20148 Milan, Italy Share capital Euro 26,140,644.5 fully paid-up to the Milan Tax Code / VAT number 00748210150 REA Milan n. 401832 delivered by Tech Style Site Services Alert service Legal notices Privacy Policy Latest news October 16, 2018 Cariprazina is coming to Italy. New drug for schizophrenia 15 October 2018 Premature ejaculation: the new spray formulation therapy

Recordati in the World pharmaceutical business (click for full menu) Italian | English Company data Recordati SpA via M. Civitali 1, 20148 Milan, Italy Share capital Euro 26,140,644.5 fully paid-up to the Milan Tax Code / VAT number 00748210150 REA Milan n. 401832 delivered by Tech Style Site Services Alert service Legal notices Privacy Policy Latest news 12 September 2018 THE IX EDITION OF THE INTERNATIONAL AWARD FOR SCIENTIFIC RESEARCH ARRIGO RECORDATI LAUNCHED 3 August 2018 Attribution of Stock Options